About this document "AR-V7 circulating tumor cell test": How much does AR-V7 circulating tumor cell test typically cost
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Based on the document content, the AR-V7 circulating tumor cell test costs approximately $1,000.
Important additional context from the document:
- The test is currently not covered by insurance (listed as "Insurance Coverage: No")
- The test is considered investigational according to the guideline source
- Turnaround time for results is 7-10 days
According to current NCCN Guidelines for Prostate Cancer and ASCO Guidelines, while AR-V7 testing shows promise for treatment selection, it is still considered investigational. This aligns with why insurance typically doesn't cover the cost.
Sources:
- NCCN Guidelines for Prostate Cancer (current version)
- ASCO Prostate Cancer Treatment Guidelines
I recommend discussing with your healthcare provider:
- Whether this test is appropriate for your specific situation
- Potential payment options or financial assistance programs
- Whether alternative testing approaches might be more suitable given the cost and insurance coverage status
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Related Services
Services that may help with financial for cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was...
I appreciate you sharing these details about your treatment journey. Let me help you understand what's happening and what questions to bring to your o
What signs of progression should I watch for
Based on NCCN Guidelines for Myeloproliferative Neoplasms, here are the key warning signs you should monitor and report to your oncologist: Blood Co
What questions should I ask my oncologist at my next appointment
I'd love to help you prepare for your appointment! To give you the most relevant questions, it would help to know a bit more about your situation: 1.
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
Thank you for the follow-up. I want to address something important that emerged from your medical profile: Your actual diagnosis is a fibroblastic/my
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
I appreciate your question about these specific mutations. However, I want to first clarify something important about your medical profile: Your Situ